Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BiomX Inc. COmmon Stock (NY:PHGE)

6.300 +1.430 (+29.36%)
Official Closing Price Updated: 4:10 PM EST, Mar 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BiomX Inc. COmmon Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages
From BiomX Inc.
Via Business Wire
News headline image
BiomX to Present Preclinical Results with BX004 in Cystic Fibrosis at the 44th European Cystic Fibrosis Conference
From BiomX Inc.
Via Business Wire
News headline image
BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates
From BiomX Inc.
Via Business Wire
News headline image
Earnings Scheduled For May 24, 2021 ↗
Companies Reporting Before The Bell • Genetron Holdings (NASDAQ:GTH) is expected to report quarterly loss at $0.18 per share on revenue of $14.21 million. • MICT... 
Via Benzinga
News headline image
BiomX to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 24, 2021
From BiomX Inc.
Via Business Wire
News headline image
BiomX to Present at Upcoming April Investor Events
From BiomX Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021 ↗
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.